PNPLA7 and prostate carcinoma: Finally, tissue-level analysis of patient samples demonstrated that PNPLA7 was expressed at lower levels in bladder, kidney, and prostate cancers compared to adjacent normal tissues (all p < 0.05, Fig. 9A–C), further supporting its relevance in these malignancies.